| abstract |
The present invention relates to formulations suitable for parenteral administration, wherein the formulations comprise an amylin or an amylin agonist, or a salt thereof. The invention further relates to the use of an amylin or an amylin agonist for the preparation of a pharmaceutical composition for treating or preventing gastritis in a subject, comprising administering to said subject a therapeutically effective amount of an amylin or an amylin agonist, wherein said amylin agonist is not a calcitonin and said amylin or amylin agonist is not administered intracerebroventricularly. |